Related Experiment Video
Updated: Jul 6, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
Newer cytotoxic agents: attacking cancer broadly.
1Genzyme Corporation, Framingham, Massachusetts 01701-9322, USA. Beverly.Teicher@Genzyme.com
Summary
Next-generation cytotoxic agents, including novel platinum compounds, microtubule inhibitors, and proteasome inhibitors, show broad potential against various cancers. These agents target cancer genome instability and cellular processes for improved antitumor effects.
Area of Science:
- Oncology
- Cancer Therapeutics
- Molecular Biology
Background:
- Cancer genome plasticity necessitates new broadly active cytotoxic agents.
- Platinum-based regimens and microtubule-targeting agents are established cancer treatments.
- Emerging targets include aurora kinases and the proteasome.
Purpose of the Study:
- To review the current status of next-generation cytotoxic agents.
- To highlight agents with potential broad activity across multiple cancer types.
- To discuss novel platinum complexes, microtubule agents, and proteasome inhibitors.
Main Methods:
- Review of recent scientific literature on novel anticancer agents.
- Discussion of drug mechanisms targeting DNA, microtubules, and protein regulation.
- Synthesis of information on agents like satraplatin, picoplatin, vinflunine, epothilones, and bortezomib.
Main Results:
- Newer platinum complexes (satraplatin, picoplatin) form bulkier DNA lesions.
- Vinflunine exhibits vascular disrupting and antitumor effects.
- Epothilones are a new class of microtubule stabilizers.
- Aurora kinase inhibitors and proteasome inhibitors (bortezomib) are validated targets.
Conclusions:
- Next-generation cytotoxic agents offer promising therapeutic strategies.
- Targeting cancer genome instability and key cellular processes is crucial.
- These agents have the potential for broad activity in diverse cancers.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...